Banking on Immortality? Exploring the Stem Cell Supply Chain from Embryo to Therapeutic Application

Bibliographic Data

ID2305233
AuthorsPeter Glasner (corresponding author)
Year2005
Volume53
Issue2
Pages355-366
Publication date2005-03-01
Peer ReviewedYes
Open AccessYes
TypeARTICLE
VenueCurrent Sociology (JOURNAL)
Journal identifiersISSN: 0011-3921 • E-ISSN: 1461-7064
PublisherSAGE Publications Inc (PUBLISHER)
DOI10.1177/0011392105049545
OpenAlexW2146247095
LanguageEN
Citations received18
References cited16

This article addresses a number of difficult and controversial issues surrounding the development of stem cell lines from embryonic stem cells derived from unused embryos during IVF treatment. The UK has recently established the world's first Stem Cell Bank to be a repository for stem cell lines from the UK and elsewhere, and to make them available for use by both academic and commercial laboratories around the world. It will not accept material from embryos specifically created for the purposes of research. However, this novel development poses a number of interesting sociological questions that will be explored in detail. As the stem cell lines are effectively immortal the provenance of any donation will need to be carefully scrutin-ized. How will the required information about whether appropriate informed consent has been obtained, whether the donors are traceable or anonymous, and where any intellectual property rights may reside, or be established? Of particular interest will be the basis for achieving standardization of practice across the variety of stakeholders (laboratories, clinics, patients, pharmaceutical companies, regulatory authorities, etc.) involved. Finally, while the UK has one of the most liberal, but also the most regulated governance structures within which to work, it appears that most of the attention is focused on tissue collection, leaving downstream therapeutic application (which may never materialize) by commercial interests relatively ungoverned. Provenance, standardization and governance in the 'supply chain' of embryonic stem cell lines may therefore provide a basis for better understanding the global commodification of 'life

Bioinformatics · Biology · Business · Commodification · Corporate governance · Donation · Economics · Economy · Embryonic stem cell · Engineering ethics · Intellectual property · Political science · Public relations · Sociology · Standardization · Stem cell · Tissue bank · Variety (cybernetics) · Biomedical Ethics and Regulation · Computer Science · Engineering · Finance · Genetics · Law · Neuroethics, Human Enhancement, Biomedical Innovations · Pluripotent Stem Cells Research

Tools

Open DOISci-Hub